Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05349630 · ClinicalTrials.gov registry record · Early Phase 1
Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
A Early Phase 1 study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT05349630: Clinical Trial Early Phase 1 study, sponsored by University of Colorado, Denver.
NCT05349630 is a Early Phase 1 study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05349630, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.
Primary Outcome
Workload in Watts at peak exercise on upright cycle ergometer
Interventions
- DRUG Ferrous sulfate 325mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2028-03 |
| Est. Completion | 2030-05 |
| Phase | Early Phase 1 |
What is known before NCT05349630 opens enrollment
NCT05349630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Ferrous sulfate 325mg is the first listed.
NCT05349630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05349630 about?
NCT05349630 is a clinical study titled "Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia". The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.
What is the current status of trial NCT05349630?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2028-03. Estimated completion is 2030-05.
What interventions are being tested in trial NCT05349630?
The interventions under investigation include: Ferrous sulfate 325mg (DRUG).
Who is sponsoring clinical trial NCT05349630?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05349630's enrollment target sits among peer trials
5 1887th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia